References
- Arnow W. S., Kaplan M. A. Propranolol combined with isosorbide dinitrate versus placebo in angina pectoris. New Engl. J. Med. 1969; 280: 847–850
- Zeft H. J., Patterson S., Orgain E. S. The effect of propranolol in the long-term treatment of angina pectoris. Arch. Intern. Med. 1969; 124: 578–583
- Shanks R. G., Hadden D. R., Lowe D. C., McDevitt D. G., Montgomery D. A. D. Controlled trial of propranolol in thyrotoxicosis. Lancet 1969; I: 993–994
- Leszkovsky G., Tardos L. Some effects of propranolol on the central nervous system. J. Pharm. Pharmacol. 1965; 17: 518–519
- Murmann W., Almirante L., Saccani-Guelfi M. Central nervous system effects of four beta-adrenergic receptor blocking agents. J. Pharm. Pharmacol. 1966; 18: 317–318
- Nordenfelt O. Orthostatic ECG changes and the adrenergic beta-receptor blocking agent, propranolol (Inderal). Acta Med. Scand. 1965; 178: 393–401
- Turner P., Granville-Grossman K. L., Smart J. V. Effect of adrenergic receptor blockade on the tachycardia of thyrotoxicosis and anxiety state. Lancet 1965; I: 1316–1318
- Hinshelwood R. D. Hallucinations and propranolol. Brit. Med. J. 1969; 2: 445
- Prichard B. N. C., Gillam P. M. S. Use of propranolol (Inderal) in treatment of hypertension. Brit. Med. J. 1964; 2: 725–727
- Mostyn R. H. Tinnitus and propranolol. Brit. Med. J. 1969; 1: 776